Soluble ST2 and Galectin-3 and Progression of CKD

Volume: 4, Issue: 1, Pages: 103 - 111
Published: Jan 1, 2019
Abstract
Cardiac biomarkers soluble ST2 (sST2) and galectin-3 may reflect cardiac inflammation and fibrosis. It is plausible that these mechanisms may also contribute to the progression of kidney disease. We examined associations of sST2 and galectin-3 with kidney function decline in participants with chronic kidney disease (CKD).This was a pooled analysis of 2 longitudinal cohorts of participants with CKD: the Clinical Phenotyping and Resource Biobank...
Paper Details
Title
Soluble ST2 and Galectin-3 and Progression of CKD
Published Date
Jan 1, 2019
Volume
4
Issue
1
Pages
103 - 111
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.